InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,612.80
(
0.00%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.24
(
-0.76%
)
Bitcoin
62,271.96
(
-0.10%
)
Post# of 10489
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

running bull

Send PM Follow Ignore
Followers 23
Posts 3943
Boards Moderated 0
Alias Born 08/11/2011

running bull

Re: None

Monday, 01/19/2015 3:02:34 PM

Monday, January 19, 2015 3:02:34 PM

Post# of 10489
I just finished reading Galena's 2015 outlook news release. There new drug Neuvax cancer immunotherapy agent which is in phase 3 and enrolling 700 patients to treat nausea and vomiting caused by chemotherapy and radiation therapy following surgery. Galena also has Gale -301 & Gale 401 in phase 2 programs plus the launch of a new drug Zuplenz. IMO if any one of these new drugs are successful Galena will be back to the stock price that it should be. JMO do your own DD
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up